← FDA DRUG APPROVALS

FDA ANDA · ANDA076694

QUINAPRIL HYDROCHLORIDE

Sponsor: PHARMOBEDIENT

APPLICATION
ANDA076694
TYPE
ANDA
ORIGINAL APPROVAL
2004-12-23
LATEST ACTION
2025-10-23
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

QUINAPRIL HYDROCHLORIDEDiscontinued
QUINAPRIL HYDROCHLORIDE EQ 40MG BASE · TABLET · ORAL
QUINAPRIL HYDROCHLORIDEDiscontinued
QUINAPRIL HYDROCHLORIDE EQ 10MG BASE · TABLET · ORAL
QUINAPRIL HYDROCHLORIDEDiscontinued
QUINAPRIL HYDROCHLORIDE EQ 20MG BASE · TABLET · ORAL
QUINAPRIL HYDROCHLORIDEDiscontinued
QUINAPRIL HYDROCHLORIDE EQ 5MG BASE · TABLET · ORAL

Approval history

2025-10-23Labeling · Supplement 13 · standardAP
2025-10-23Labeling · Supplement 14 · standardAP
2011-02-17Labeling · Supplement 10AP
2006-04-28Labeling · Supplement 5AP
2004-12-23OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →